RSKD insider plans sale of 286,599 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RSKD reports that an affiliate has filed to potentially sell 286,599 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an aggregate market value of $1,848,563.55 as of a planned sale date of August 14, 2026.
The shares consist of 250,000 founders shares acquired on November 26, 2012 and 36,599 restricted stock units dated October 1, 2025. The filing also lists recent sales under a Rule 10b5-1 trading plan by Assaf Feldman, including 450,000 shares sold on August 12, 2026 and additional sales in July 2026.
Key Figures
Key Terms
Restricted Stock Units financial
10b5-1 Sales regulatory
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent 10b5-1 plan sales by Assaf Feldman in RSKD stock are disclosed?
Is the RSKD Form 144 linked to a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.